Skip Navigation


Carcinogenesis Advance Access originally published online on August 29, 2003
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
24/12/1903    most recent
bgg157v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Bacon, J. R.
Right arrow Articles by Bao, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bacon, J. R.
Right arrow Articles by Bao, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Carcinogenesis, Vol. 24, No. 12, 1903-1911, December 2003
© Oxford University Press; all rights reserved


MOLECULAR EPIDEMIOLOGY AND CANCER PREVENTION

Sulforaphane and quercetin modulate PhIP–DNA adduct formation in human HepG2 cells and hepatocytes

James R. Bacon1, Gary Williamson1,4, R. Colin Garner2, Graham Lappin2, Sophie Langouët3 and Yongping Bao1,5

1 Institute of Food Research, Norwich Research Park, Norwich NR4 7UA, UK, 2 Xceleron Ltd, York Biocentre, Innovation Way, Heslington, York YO10 5NY, UK and 3 INSERM U456, Faculté de Pharmacie, University de Rennes I, F-35043 Rennes, France

The formation of DNA adducts in human HepG2 cells and human hepatocytes exposed to 14C-labelled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) was examined using Accelerator Mass Spectrometry (AMS). PhIP generated DNA adducts in a linear dose-dependent manner between 100 pM and 20 µM. Co-treatment with the dietary isothiocyanate, sulforaphane (SFN, 1–10 µM), or the flavonoid, quercetin (5–20 µM), significantly reduced the level of PhIP–DNA adducts in a dose-dependent manner. The degree of protection was dependent on PhIP concentration, i.e. after 100 pM PhIP exposure, SFN or quercetin reduced adduct levels to below the limit of detection (0.15 amol PhIP/µg DNA) but at higher PhIP exposure (10 nM and 1 µM), the protection was 60 and 10%, respectively. The involvement of phase I, phase II and DNA repair enzymes in this protection against PhIP–DNA adduct formation was investigated using real-time RT–PCR and enzyme activity assays. In intact HepG2 cells, quercetin inhibited cytochrome P450 (CYP)1A2, the main phase I enzyme responsible for PhIP bioactivation. In contrast, SFN induced phase II detoxification enzymes, UDP-glucuronosyltransferase 1A1 and glutathione S-transferase A1 mRNA expression. SFN and quercetin showed no effect on DNA repair, neither in terms of the level of PhIP–DNA adducts, when cells were treated with phytochemicals after the carcinogen exposure, nor the regulation of mRNA expression of two DNA repair enzymes, apurinic endonuclease and DNA polymerase ß. This study indicates that dietary isothiocyanates and flavonoids modulate phase I and phase II enzyme expression, hence increasing the rate of detoxification of the dietary carcinogen PhIP in human HepG2 cells but do not affect the rate of PhIP–DNA adduct repair. The formation of PhIP–DNA adducts in human hepatocytes was also dose-dependent with PhIP-concentration and the levels of protection by SFN or quercetin were up to 60% after 10 nM PhIP treatment, but showed large inter-individual variation with no observed protection in some individuals.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cancer Res.Home page
L. Mastrangelo, A. Cassidy, F. Mulholland, W. Wang, and Y. Bao
Serotonin Receptors, Novel Targets of Sulforaphane Identified by Proteomic Analysis in Caco-2 Cells
Cancer Res., July 1, 2008; 68(13): 5487 - 5491.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
S. J. T. Jackson and R. C. Venema
Quercetin Inhibits eNOS, Microtubule Polymerization, and Mitotic Progression in Bovine Aortic Endothelial Cells
J. Nutr., May 1, 2006; 136(5): 1178 - 1184.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
V. Svehlikova, S. Wang, J. Jakubikova, G. Williamson, R. Mithen, and Y. Bao
Interactions between sulforaphane and apigenin in the induction of UGT1A1 and GSTA1 in CaCo-2 cells
Carcinogenesis, September 1, 2004; 25(9): 1629 - 1637.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.